Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is PW Medtech Group Ltd. ?
1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 69.46
2
Healthy long term growth as Net Sales has grown by an annual rate of 23.04%
3
Negative results in Dec 24
- INTEREST(HY) At HKD 0.28 MM has Grown at 179.41%
4
With ROE of 4.97%, it has a Attractive valuation with a 0.52 Price to Book Value
- Over the past year, while the stock has generated a return of 30.39%, its profits have fallen by -7.4%
5
Consistent Returns over the last 3 years
- Along with generating 30.39% returns in the last 1 year, the stock has outperformed Hang Seng Hong Kong in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to PW Medtech Group Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is PW Medtech Group Ltd. for you?
Low Risk, Medium Return
Absolute
Risk Adjusted
Volatility
PW Medtech Group Ltd.
30.39%
0.75
32.40%
Hang Seng Hong Kong
26.67%
1.03
25.88%
Quality key factors
Factor
Value
Sales Growth (5y)
23.04%
EBIT Growth (5y)
42.60%
EBIT to Interest (avg)
69.46
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.42
Sales to Capital Employed (avg)
0.13
Tax Ratio
16.20%
Dividend Payout Ratio
92.54%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.88%
ROE (avg)
8.97%
Valuation Key Factors 
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
0.52
EV to EBIT
2.89
EV to EBITDA
1.54
EV to Capital Employed
0.17
EV to Sales
0.50
PEG Ratio
NA
Dividend Yield
1.42%
ROCE (Latest)
5.96%
ROE (Latest)
4.97%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for PW Medtech Group Ltd.
Operating Cash Flow
Highest at HKD 675.14 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Net Sales
Highest at HKD 467 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (HKD MM)
EPS
Highest at HKD 0.06
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (HKD)
Debtors Turnover Ratio
Highest at 2.62%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Dividend Payout Ratio
Highest at 92.98%
in the last five yearsMOJO Watch
Company is distributing higher proportion of profits generated as dividend
DPR (%)
Depreciation
Highest at HKD 72.99 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (HKD MM)
Depreciation
At HKD 72.99 MM has Grown at 33.48%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for PW Medtech Group Ltd.
Interest
At HKD 0.28 MM has Grown at 179.41%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)






